Cellebrite DI Ltd. $CLBT Shares Sold by Acadian Asset Management LLC

Acadian Asset Management LLC decreased its position in Cellebrite DI Ltd. (NASDAQ:CLBT) by 35.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,533,492 shares of the company’s stock after selling 1,384,958 shares during the quarter. Acadian Asset Management LLC owned about 1.06% of Cellebrite DI worth $40,516,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Signaturefd LLC increased its holdings in shares of Cellebrite DI by 68.3% in the second quarter. Signaturefd LLC now owns 2,019 shares of the company’s stock valued at $32,000 after buying an additional 819 shares in the last quarter. Assetmark Inc. purchased a new stake in shares of Cellebrite DI in the first quarter valued at $33,000. Virtus Advisers LLC purchased a new stake in shares of Cellebrite DI in the first quarter valued at $63,000. Hennessy Advisors Inc. acquired a new stake in shares of Cellebrite DI in the second quarter worth $83,000. Finally, Advisors Asset Management Inc. grew its holdings in shares of Cellebrite DI by 24.7% during the first quarter. Advisors Asset Management Inc. now owns 6,133 shares of the company’s stock valued at $119,000 after buying an additional 1,214 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Up 0.9%

Shares of NASDAQ:CLBT opened at $15.40 on Monday. The company has a market cap of $3.69 billion, a price-to-earnings ratio of -20.26, a PEG ratio of 3.16 and a beta of 1.28. The business has a 50 day moving average price of $17.76 and a 200 day moving average price of $16.75. Cellebrite DI Ltd. has a twelve month low of $13.10 and a twelve month high of $26.30.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, August 14th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The company had revenue of $113.28 million during the quarter, compared to analysts’ expectations of $112.33 million. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.Cellebrite DI’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.10 earnings per share. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts anticipate that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Weiss Ratings upgraded Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. JPMorgan Chase & Co. lifted their price objective on Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a research report on Wednesday, September 24th. Lake Street Capital lowered their price target on Cellebrite DI from $24.00 to $22.00 and set a “buy” rating for the company in a research note on Friday, August 15th. Wall Street Zen cut shares of Cellebrite DI from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Needham & Company LLC decreased their target price on shares of Cellebrite DI from $24.00 to $18.00 and set a “buy” rating for the company in a research report on Thursday, August 14th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Cellebrite DI has a consensus rating of “Moderate Buy” and an average price target of $21.00.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.